Guy Rachmuth

By Jane Myles and Aaron Kamau What are real-world data (RWD) and real-world evidence (RWE), and how can we overcome the challenges of integrating them into clinical trials to produce better outcomes?

Newsletter | November 8, 2021 By Ed Miseta, chief editor, Clinical Leader There has been a push in recent years to increase the liquidity of patient data and make those data more accessible to the patients from whom it was gathered. But increasing the liquidity of data also increases concerns around privacy and ethics. By Clinical Leader Live The complexity of initiating clinical studies continues to grow.

Newsletter | July 14, 2021 By Stephen Kemler, RSM US LLP At the worst point during the pandemic, year-on-year enrollment of new patients globally was down 59% in April 2020. By August of 2020 (the last update published), the year-on-year impact was down only 20%. This article explores how clinical execs adapted to the pandemic's demands and offers two questions for introspection regarding patient recruitment going forward.